immune modulation in PD : Scientists achi... - Cure Parkinson's

Cure Parkinson's

26,300 members27,660 posts

immune modulation in PD : Scientists achieve research milestone

aspergerian profile image
3 Replies

Scientists achieve research milestone with Parkinson's disease

Date: March 27, 2017

Source: University of Nebraska Medical Center (UNMC)

Summary: In a Phase I clinical study, researchers were able to transform

the immune system by taking cells damaged in Parkinson’s disease and

making them cells that protect and defend against brain injury.

sciencedaily.com/releases/2...

* * * *

open access

Evaluation of the safety and immunomodulatory effects of sargramostim in

a randomized, double-blind phase 1 clinical Parkinson’s disease trial

nature.com/articles/s41531-...

Written by
aspergerian profile image
aspergerian
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Marcomando profile image
Marcomando

Sounds promising - like so many of these trials...

Still waiting

Catlou profile image
Catlou

So this is a repurposed drug originally used to increase t-cells. In that case off it works can't they apply for that special status to move things along?

aspergerian profile image
aspergerian in reply to Catlou

Perhaps Dr. Gendelman (lead author) would appreciate a note of appreciation and encouragement.

Howard E. Gendelman

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA

Contact Howard E. Gendelman

nature.com/articles/s41531-...

Not what you're looking for?

You may also like...

Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD

Highlights • Oral NR increases brain NAD levels in individuals with Parkinson’s disease • NR...

Stem Cells Trials

I want to make a list here. Please reply with links...

Fasudil-treated, intranasally-delivered, bone-marrow-derived stem cells ... in a mouse model of PD

It sounds like a breakthrough. But how long before a Phase 1 clinical trial? PNT article -...

New Clinical Trial Starting: A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (REGENERATE-PD)

Here is a link to the trial on clinicaltrials.gov...

ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)

https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?releaseID=111474&d=20